A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...

Eli Lilly's $7 billion deal for Kelonia Therapeutics on Monday was just the latest example | Despite the recent “feeding ...

Chimeric antigen receptor T-cell therapy conferred sustained benefit to individuals with high-risk smoldering multiple myeloma, according to phase 2 trial results. All patients who received a single ...

A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a ...

A personalized CAR T-cell therapy has sent a patient with three life-threatening autoimmune diseases into remission for over a year, after conventional treatments failed. The case adds to mounting ...

Therapies like PRP and ACS have gained credibility when properly applied and studied, particularly in musculoskeletal conditions.

Off-the-shelf cema-cel clears MRD at more than triple the rate of observation alone—and may propel a shift to frontline use ...

Roswell Park Comprehensive Cancer Center has opened a clinical trial to test whether CAR T-cell therapy—successful in some blood cancers—can treat autoimmune diseases like systemic sclerosis, with ...

Researchers at the University of British Columbia Faculty of Medicine have developed a new targeted cancer therapy that can ...

At AACR, first‑in‑human KIR‑CAR T data show early activity in solid tumors and introduce a novel design aimed at limiting T ...

Four of nine patients responded to the mesothelin-directed therapy, which uses a multi-chain receptor borrowed from NK cells, ...